Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH VENUS REMEDIES WYETH/
VENUS REMEDIES
 
P/E (TTM) x 27.7 14.9 186.5% View Chart
P/BV x 11.3 0.9 1,200.9% View Chart
Dividend Yield % 10.9 0.0 -  

Financials

 WYETH   VENUS REMEDIES
EQUITY SHARE DATA
    WYETH
Mar-14
VENUS REMEDIES
Mar-23
WYETH/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,065379 281.1%   
Low Rs553145 381.4%   
Sales per share (Unadj.) Rs289.5415.5 69.7%  
Earnings per share (Unadj.) Rs38.719.9 194.8%  
Cash flow per share (Unadj.) Rs39.944.0 90.6%  
Dividends per share (Unadj.) Rs145.000-  
Avg Dividend yield %17.90-  
Book value per share (Unadj.) Rs118.5344.3 34.4%  
Shares outstanding (eoy) m22.7213.37 169.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.80.6 443.4%   
Avg P/E ratio x20.913.2 158.6%  
P/CF ratio (eoy) x20.35.9 340.8%  
Price / Book Value ratio x6.80.8 897.4%  
Dividend payout %374.70-   
Avg Mkt Cap Rs m18,3813,501 525.0%   
No. of employees `000NANA-   
Total wages/salary Rs m359570 62.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,5775,555 118.4%  
Other income Rs m347103 336.6%   
Total revenues Rs m6,9255,658 122.4%   
Gross profit Rs m1,023602 170.0%  
Depreciation Rs m27323 8.5%   
Interest Rs m43 149.3%   
Profit before tax Rs m1,339379 353.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460114 404.4%   
Profit after tax Rs m879266 330.9%  
Gross profit margin %15.610.8 143.6%  
Effective tax rate %34.330.0 114.6%   
Net profit margin %13.44.8 279.5%  
BALANCE SHEET DATA
Current assets Rs m3,9643,230 122.7%   
Current liabilities Rs m2,081826 252.0%   
Net working cap to sales %28.643.3 66.2%  
Current ratio x1.93.9 48.7%  
Inventory Days Days3537 95.0%  
Debtors Days Days278504 55.1%  
Net fixed assets Rs m8782,781 31.6%   
Share capital Rs m227134 170.0%   
"Free" reserves Rs m2,4664,470 55.2%   
Net worth Rs m2,6934,603 58.5%   
Long term debt Rs m25387 6.5%   
Total assets Rs m4,8426,011 80.6%  
Interest coverage x306.0130.0 235.3%   
Debt to equity ratio x00.1 11.1%  
Sales to assets ratio x1.40.9 147.0%   
Return on assets %18.24.5 408.4%  
Return on equity %32.65.8 565.7%  
Return on capital %49.47.7 645.2%  
Exports to sales %0.10-   
Imports to sales %34.70-   
Exports (fob) Rs m8NA-   
Imports (cif) Rs m2,281NA-   
Fx inflow Rs m80-   
Fx outflow Rs m2,2980-   
Net fx Rs m-2,2910-   
CASH FLOW
From Operations Rs m1,188366 324.4%  
From Investments Rs m287-508 -56.4%  
From Financial Activity Rs m-4,296-6 75,632.4%  
Net Cashflow Rs m-2,821-220 1,279.6%  

Share Holding

Indian Promoters % 0.0 41.8 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 18.4 1.6 1,156.0%  
FIIs % 0.0 1.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.9 58.2 83.9%  
Shareholders   25,706 19,560 131.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on WYETH vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

WYETH vs VENUS REMEDIES Share Price Performance

Period WYETH VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -2.27% 5.90% 1.23%
1-Month 18.58% -5.13% -0.70%
1-Year 69.59% 100.93% 61.90%
3-Year CAGR 15.36% 4.25% 18.18%
5-Year CAGR 8.95% 57.71% 19.80%

* Compound Annual Growth Rate

Here are more details on the WYETH share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of WYETH hold a 51.1% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of WYETH, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.